FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Corrects Notice on Withdrawn Drug Products

[ Price : $8.95]

Federal Register Proposed rule: FDA corrects the Regulatory Information Number in a 7/2 notice on additions and modifications to a...

FDA Clears K2M Capri Corpectomy Cage System

[ Price : $8.95]

FDA clears a K2M 510(k) for its Capri Corpectomy Cage System, an expandable vertebral body replacement device for use following a ...

Frivolous Petitions Continue to be Submitted: FDA

[ Price : $8.95]

A new report from FDA to Congress says the agency is concerned that too many petitions continue to be submitted as a strategy to d...

FDA Evaluating Higher Death Rate with Dual Antiplatelet Therapy

[ Price : $8.95]

FDA says it is evaluating preliminary data from a clinical trial showing an increased overall risk of death for patients on dual a...

Genzyme Gains Approval for Lemtrada for MS

[ Price : $8.95]

FDA approves a Genzyme NDA for Lemtrada (alemtuzumab) for treating patients with relapsing forms of multiple sclerosis.

Solgar Recalls Dietary Supplement Due to Fungus

[ Price : $8.95]

Solgar, Inc. recalls its ABC Dophilus Powder after testing by the Centers for Disease Control revealed the presence of Rhizopus or...

FDA Seeking to Double Inspectional Presence In China

[ Price : $8.95]

FDA says an ongoing hold on China-issued visas is expected to be lifted in the coming weeks which will double its inspectional pre...

84% Say CDRH Delivering Good Customer Service

[ Price : $8.95]

An ongoing CDRH customer survey finds that 84% of respondents are satisfied with the Centers customer service.

Kremers Urban Generic Concerta Downgraded Due to BE Concerns

[ Price : $8.95]

FDA tells Kremers Urban Pharmaceuticals that it will need to conduct an additional bioequivalence study based on a recently issued...

Industry Wants More Guidance on Biomarker Use in Trials

[ Price : $8.95]

Pharmaceutical Research and Manufacturers of America says FDA should develop a guidance document on conducting trials in biomarker...